Global AAV Production Service Market Growth (Status and Outlook) 2024-2030

Global AAV Production Service Market Growth (Status and Outlook) 2024-2030

AAV Production Service refers to the Adeno-Associated Virus (AAV) production service provided by a contract research organization (CRO) or a biotechnology company. AAV is a viral vector commonly used in gene therapy. Due to its low immunogenicity, wide tissue infection ability and good safety, it has important applications in the treatment of genetic diseases and the development of gene therapy drugs.

The global AAV Production Service market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.

LPI (LP Information)' newest research report, the “AAV Production Service Industry Forecast” looks at past sales and reviews total world AAV Production Service sales in 2022, providing a comprehensive analysis by region and market sector of projected AAV Production Service sales for 2023 through 2029. With AAV Production Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world AAV Production Service industry.

This Insight Report provides a comprehensive analysis of the global AAV Production Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on AAV Production Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global AAV Production Service market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for AAV Production Service and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global AAV Production Service.

United States market for AAV Production Service is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for AAV Production Service is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for AAV Production Service is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key AAV Production Service players cover Genemedi, Addgene, Lonza, SIRION Biotech, BioMarin, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of AAV Production Service market by product type, application, key players and key regions and countries.

Segmentation by Type:
Custom AAV Production
GMP Grade Production
Others

Segmentation by Application:
Gene Therapy
Vaccine Development
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

Segmentation by Type:
Custom AAV Production
GMP Grade Production
Others

Segmentation by Application:
Gene Therapy
Vaccine Development
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Genemedi
Addgene
Lonza
SIRION Biotech
BioMarin
AGC Biologics
TAAV
GeneCopoeia
Virovek
Vigene Biosciences
GenScript
WuXi AppTec
AMSBIO

Please note: The report will take approximately 2 business days to prepare and deliver.